Blackstone Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-517,391
| Closed | -$84.5M | – | 249 |
|
|
2022
Q1 | $84.5M | Hold |
517,391
| – | – | 0.21% | 46 |
|
|
2021
Q4 | $87.7M | Hold |
517,391
| – | – | 0.22% | 58 |
|
|
2021
Q3 | $97.7M | Hold |
517,391
| – | – | 0.22% | 57 |
|
|
2021
Q2 | $87.7M | Sell |
517,391
-120,436
| -19% | -$20.4M | 0.2% | 52 |
|
|
2021
Q1 | $90.1M | Hold |
637,827
| – | – | 0.18% | 45 |
|
|
2020
Q4 | $82.9M | Sell |
637,827
-178,245
| -22% | -$23.2M | 0.29% | 36 |
|
|
2020
Q3 | $119M | Sell |
816,072
-108,609
| -12% | -$15.8M | 0.46% | 28 |
|
|
2020
Q2 | $137M | Buy |
+924,681
| New | +$137M | 0.58% | 25 |
|